ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

4.31
Delayed Data
As of Apr 20
 +0.03 / +0.70%
Today’s Change
3.33
Today|||52-Week Range
7.88
+4.11%
Year-to-Date
No recent news for ZIOPHARM Oncology Inc.

Today’s Trading

Previous close4.28
Today’s open4.25
Day’s range4.24 - 4.37
Volume662,903
Average volume (3 months)1,613,199
Market cap$618.0M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+59.85%
Earnings growth (this year)-1.89%
Earnings growth (next 5 years)--
Revenue growth (last year)-6.88%
P/E ratioNM
Price/Sales88.73
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ADROAduro Biotech Inc-0.15-2.11%
HRTXHeron Therapeutics I...+1.30+4.36%
BYSIBeyondspring Inc+3.60+13.09%
TGTXTG Therapeutics Inc-0.30-2.04%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$6.4M
Annual profit (last year)-$54.3M
Net profit margin-850.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Laurence James Neil Cooper
Executive VP, Chief Operating &
Business Officer
David M. Mauney
Corporate headquarters
Boston, Massachusetts

Forecasts